Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions
Sezen Vatansever, Avner Schlessinger, Daniel Wacker et al. · Medicinal Research Reviews · 2020 · Review
Full textCC BY